Biogen (BIIB) Stock Gains Bullish Upgrade Ahead of Key Alzheimer’s Data Release
Truist upgrades Biogen (BIIB) to Buy with $235 target ahead of July 14 Alzheimer's drug diranersen data reveal at AAIC conference in London. The post Biogen (BIIB) Stock Gains Bullish Upgrade Ahead…
Read the full articleYou might also wanna read
Alcoa Corporation (AA) Stock: Slides Following Strong Q2 Results and $4.1B South32 Acquisition
parameter.io·4h ago
Intuitive Surgical, Inc. (ISRG) Stock: Surges as Q2 Revenue Jumps 19% and Robotic Surgery Growth Shines
parameter.io·4h ago
Broadcom Inc. (AVGO) Stock: Shares Slip 5% as Standard Chartered Expands VMware Cloud Partnership
parameter.io·5h ago
CrowdStrike Holdings, Inc. (CRWD): Stock Faces Pressure as Identity Threat Detection Leadership Expands
parameter.io·5h ago
UnitedHealth Group (UNH) Stock: Profit Growth, AI Investments and Cost Discipline Fuel 2026 Momentum
parameter.io·5h ago
The Eastern Company (EML) Stock: Earnings Report and Webcast Details Released Ahead of August Call
parameter.io·5h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.